Miostat Injection (Carbachol Intraocular Solution) 0.01% x 12 Vials Per Box
How to Order:
You will receive instructions on how to create an account along with Rx Ordering Details.
(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Miostat Injection, containing 0.01% Carbachol, is an intraocular solution is designed to induce miosis during ocular surgery. Supplied in a convenient box of 12 vials, Miostat ensures precise control over intraoperative iris motion for enhanced surgical outcomes.
#1 Surgical Solution for Intraocular Miosis and Ophthalmic Surgery | Trusted by Eye Specialists Worldwide
Miostat Injection (Carbachol Intraocular Solution) 0.01% is a leading ophthalmic pharmaceutical designed for rapid, safe, and effective induction of miosis during cataract and other anterior segment eye surgeries. Each prescription-strength box contains 12 single-use sterile vials, ensuring optimal sterility and efficacy for every procedure.
How to Use:
For intraocular administration by ophthalmic surgeons only. Instill the recommended dose into the anterior chamber of the eye during surgery according to surgical protocols. Not for topical or systemic use.
Product Highlights & Key Health Benefits:
- Optimal Intraocular Miosis: Miostat (carbachol) delivers immediate, sustained pupil constriction, leading to maximum intraoperative visibility and control for surgeons.
- Enhanced Surgical Safety: Reduces the risk of postoperative complications such as elevated intraocular pressure (IOP) and iris prolapse.
- Rapid-Acting Formula: Onset of miosis typically within minutes, providing optimal readiness for lens implantation and capsulorhexis.
- Sterile, Single-Use Vials: Maintains highest standards of infection prevention and pharmaceutical quality with 12 single-dose vials per box.
- FDA-Approved, Ophthalmologist Recommended: Suitable for use in cataract extraction, glaucoma filtration surgery, and other anterior segment procedures.
Why Choose Miostat (Carbachol Intraocular Solution) 0.01%?
- Reliable Pupil Control: Consistently achieves intraoperative miosis crucial for safe cataract extraction and other anterior segment procedures.
- IOP Regulation: Proven to assist in controlling intraocular pressure (IOP) after lens replacement or glaucoma surgery.
- Preservative-Free & Non-Pyrogenic: Formulated for patient safety, Miostat contains no preservatives and poses minimal risk of postoperative inflammation.
- Convenient Packaging: Each box contains 12 sterile, single-use vials—ideal for surgical centers and eye care clinics.
Indications & Usage:
Miostat Injection (carbachol intraocular solution) 0.01% is FDA-approved for intraocular use during cataract surgery and other anterior segment procedures to promptly induce miosis and mitigate postoperative increases in intraocular pressure.
Clinically Trusted For:
- Cataract extraction
- Lens implantation (IOL procedures)
- Glaucoma filtration surgery (trabeculectomy)
- Anterior segment surgical miosis
- Postoperative IOP reduction